Current Assets
Inventories
Pfizer Inventories increased by 397.4% to $10.65B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.8%, from $10.85B to $10.65B. Over 5 years (FY 2020 to FY 2025), Inventories shows an upward trend with a 5.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ3 2015
Last reportedQ4 2025
How to read this metric
An increase might suggest overproduction or weakening demand, while a decrease could indicate strong sales or potential supply chain shortages.
Detailed definition
The carrying value of raw materials, work-in-process, and finished goods awaiting sale to consumers or enterprise client...
Peer comparison
Consumer electronics firms strive for high inventory turnover to mitigate the risk of rapid technological depreciation.
Metric ID:
inventoriesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $981.00M | $935.00M | $9.06B | $894.00M | $943.00M | $3.33B | $8.98B | $5.62B | $5.87B | $1.42B | $10.19B | $3.36B | $2.92B | $2.77B | $10.85B | $2.79B | $2.36B | $2.14B | $10.65B |
| QoQ Change | — | -4.7% | +868.9% | -90.1% | +5.5% | +252.8% | +169.9% | -37.5% | +4.5% | -75.9% | +619.6% | -67.0% | -13.2% | -5.2% | +292.4% | -74.3% | -15.5% | -9.2% | +397.4% |
| YoY Change | — | — | — | — | -3.9% | +255.8% | -0.9% | +528.2% | +522.3% | -57.4% | +13.5% | -40.2% | -50.3% | +95.3% | +6.5% | -16.9% | -19.1% | -22.5% | -1.8% |
Range$894.00M – $10.85B
CAGR+69.9%
Avg YoY Growth+80.6%
Median YoY Growth-1.8%
Inventories at Other Companies
Frequently Asked Questions
- What is Pfizer's inventories?
- Pfizer (PFE) reported inventories of $10.65B in Q4 2025.
- How has Pfizer's inventories changed year-over-year?
- Pfizer's inventories decreased by 1.8% year-over-year, from $10.85B to $10.65B.
- What is the long-term trend for Pfizer's inventories?
- Over 5 years (2020 to 2025), Pfizer's inventories has grown at a 5.8% compound annual growth rate (CAGR), from $8.05B to $10.65B.
- What does inventories mean?
- The value of products currently being manufactured or held in stock ready to be sold.